SCHEMBL19959924

SCHEMBL19959924

S=P(c1ccccc1)(c1ccc2nc3c4ccccc4c4ccccc4n3c2c1)n1c2ccccc2c2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.39
MAPT P10636 6/20 0.39
LMNA P02545 3/20 0.39
POLB P06746 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TP53 P04637 2/20 0.39
ALDH1A1 P00352 8/20 0.38
HPGD P15428 6/20 0.38
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.34
AHR P35869 1/20 0.33
TSHR P16473 1/20 0.33
GAA P10253 2/20 0.32
HIF1A Q16665 1/20 0.32
NPC1 O15118 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19959919 0.84 KDM4E (0.40) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL19959918 0.83 KDM4E (0.33) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL19959942 0.82 KDM4E (0.38) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL19959948 0.82 KDM4E (0.38) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL19928976 0.82 KDM4E (0.42) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL22456394 0.82 KDM4E (0.42) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL19965895 0.81 KDM4E (0.38) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL19959922 0.81 KDM4E (0.38) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL19959832 0.80 KDM4E (0.36) KDM4EMAPTLMNAPOLBHSD17B10
SCHEMBL22166887 0.79 MAPT (0.33) KDM4EMAPTLMNAPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885LMNA 3023/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885LMNA 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.